0 followers
LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end-stage liver disease.
Michael Hufford
Thermo Fisher Scientific
158 followers
CRISPR Therapeutics
9 followers
Adverum Biotech
8 followers
Legend Biotech
5 followers
Artivion
3 followers
Verve Therapeutics
54 followers
Tessera Therapeutics
2 followers
Vaxcyte
2 followers
ImmunityBio
2 followers
BioAgilytix
1 follower
Dragonfly Therapeutics
1 follower
Explore companies